University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promising academic life science research to market. . . . → Read More: Health Research Commercialization Company Launched
|
|||||
|
       
  |
Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections. . . . → Read More: Merck Inks Three Covid-19 Vaccine, Therapy Deals 
A biotechnology company using gene editing for diagnostics is developing a fast, point-of-care Covid-19 test with drug maker GlaxoSmithKline. . . . → Read More: GSK, Biotech Partner on Crispr Covid-19 Test 
A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies. . . . → Read More: Venture Producing Covid-19 Antibody Test Kits 
The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic. . . . → Read More: FDA Analyzing Real-World Evidence on Covid-19 
The Food and Drug Administration asked designers of a Covid-19 test collecting samples at home for research to stop giving results to individuals. . . . → Read More: FDA Stops Home Covid-19 Diagnostic Test  One comment - (Comments are closed)  Regulations  biomedical, clinical trials, Covid-19, FDA, genomics, health care, life sciences, mathematics, medical device, university 
A clinical trial testing treatments for lung damage in severe Covid-19 cases is adding the anti-viral drug remdesivir and convalescent plasma to its protocol. . . . → Read More: Covid-19 Lung Disease Trial Adds Treatments Comments are closed New products biomedical, biotechnology, clinical trials, Covid-19, Europe, FDA, life sciences, pharmaceuticals 
The Food and Drug Administration issued new regulatory guidance on clinical trials and streamlined review processes for Covid-19 treatments. . . . → Read More: FDA Issues Covid-19 Therapy Trials, Review Guidance 2 comments - (Comments are closed) Regulations biomedical, clinical trials, Covid-19, FDA, life sciences, pharmaceuticals 
A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million. . . . → Read More: Stem Cell Therapy Licensed for Genetic Eye Disease Comments are closed Intellectual property Asia, biomedical, biotechnology, clinical trials, Europe, FDA, Japan, licensing, life sciences, pharmaceuticals, stem cells 
A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics. . . . → Read More: Biotech Gains Antibody Discovery, Manufacturing Funds Comments are closed Finance, New products biomedical, biotechnology, Canada, Covid-19, DoD, FDA, grant, life sciences, manufacturing, NIH, pharmaceuticals |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||